New synergistic combination therapy approaches with HDAC inhibitor quisinostat, cisplatin or PARP inhibitor talazoparib for urothelial carcinoma
Article in Journal of Cellular and Molecular Medicine (May 2024)
The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.
Article in Journal of Cellular and Molecular Medicine (May 2024)
Article in Saudi Medical Journal (February 2024)
Article in 动物学研究 (January 2024)